Melanoma / edited by David E. Fisher, Boris C. Bastian.
Colaborador(es): Fisher, David E, editor | Bastian, Boris C, editor | SpringerLink (Online service)
.
Tipo de material:
E-bookSeries (Medicine (Springer-11650)).Conjunto: MelanomaEditor: New York, NY : Springer New York : Imprint: Springer, 2019Edición: 1st ed. 2019.Descripción: 1 recurso en línea : (160 ilustraciones, 154 ilustraciones a color).ISBN: 9781461471479.Tema: Melanoma
| Tipo de ítem | Biblioteca actual | Colección | Signatura topográfica | Estado | Fecha de vencimiento | Código de barras | Reserva de ítems | |
|---|---|---|---|---|---|---|---|---|
LIBRO-E NO PRÉSTAMO
|
Valencia Digital Acceso Electrónico (UEV) | Ciencias de la Salud | RC280 .M37 2019 EB (Navegar estantería(Abre debajo)) | Acceso electrónico |
Acral Melanoma -- Adjuvant Therapy -- Animal Models of Melanoma -- Biology of Melanoma Metastasis -- Care of the Melanoma Patient -- Clinical Management of Primary Cutaneous Melanoma -- Combinatorial Approach to Treatment of Melanoma -- Developmental Biology of Melanocytes -- Epidemiology of Melanocytic Neoplasia -- Genetic Counseling -- Imaging Melanoma -- Immunotherapy (Clinical) -- Inherited Contributions to Melanoma Risk -- Key Signaling Pathways in Normal and Neoplastic Melanocytes.
Melanoma is a cutting edge, comprehensive reference work on the topic of melanoma. The overarching goal is to provide detailed scholarly information which broadly covers all aspects of the clinical presentation and management of the disease, as well as the biological and scientific understanding of its pathogenesis and treatment. Key topics highlighted include recent breakthroughs in molecular diagnostics, breakthroughs in targeted therapeutic approaches, overviews of signaling and transcriptional pathways, and important controversies such as screening, early diagnosis, sentinel node biopsy, and prevention strategies. In all, the volume provides a cutting edge and comprehensive presentation of the field of melanoma, written by a team of internationally renowned thought-leaders.
No hay comentarios en este titulo.